Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer

Type of Cancer
Breast Oncology

Site
Hackensack

Protocol Number
SWOG S1207

To Learn More Call
201-510-0910